文献速递针灸推拿中医康复中医骨伤

推拿治疗慢性非特异性下腰痛:随机对照试验系统评价与Meta分析

Tuina for chronic non-specific low back pain: A systematic review and meta-analysis of randomized controlled trials.
PubMed 文献 · Complement Ther Med · 2026-04-17

结果显示推拿在减轻疼痛、改善功能及临床有效率方面优于对照干预,但对肌肉适能无显著影响,证据质量多为低。

要点

  • 推拿可减轻慢性非特异性下腰痛疼痛并改善功能,但证据质量低。
  • 推拿临床有效率优于对照干预(OR=3.84)。
  • 推拿对肌肉适能及严重不良事件发生率无显著差异。

核心结论

  • 推拿可有效治疗慢性非特异性下腰痛,在疼痛缓解与功能改善方面有较大效应,但对肌肉适能无显著影响。

研究设计与样本

  • 采用Cochrane偏倚风险工具与GRADE方法评估偏倚风险与证据确定性,研究注册于PROSPERO(CRD420251051014)。

主要发现

  • 与对照干预相比,推拿减轻疼痛更明显(SMD=-1.06,95%CI:[-1.37,-0.76],p<0.00001,GRADE:低)。
  • 推拿改善功能更明显(SMD=-1.17,95%CI:[-1.62,-0.72],p<0.00001,GRADE:低)。
  • 推拿临床有效率更高(OR=3.84,95%CI:[2.42,6.11],p<0.00001,GRADE:低)。
  • 肌肉适能无显著差异(SMD=1.42,95%CI:[-0.00,2.83],p=0.05,GRADE:极低)。
  • 严重不良事件发生率无显著差异。

关键数值与推荐

  • 疼痛SMD=-1.06(95%CI:[-1.37,-0.76]),GRADE证据质量低。
  • 功能SMD=-1.17(95%CI:[-1.62,-0.72]),GRADE证据质量低。
  • 临床有效率OR=3.84(95%CI:[2.42,6.11]),GRADE证据质量低。
  • 肌肉适能SMD=1.42(95%CI:[-0.00,2.83]),GRADE证据质量极低。

临床怎么用

  • 可将推拿作为成人慢性非特异性下腰痛的非药物疗法用于缓解疼痛和改善功能。
  • 因证据质量多为低,临床决策需结合患者具体情况并关注标准化操作方案。

局限性

  • 纳入研究证据质量多为低或极低,结论需更多标准化方案和严谨设计的试验支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic non-specific low back pain (cNLBP) is a pervasive and debilitating condition with significant personal, societal, and economic burdens. Despite its prevalence, effective and sustainable non-pharmacological treatment options remain limited. Here, we compared the efficacy of Tuina versus non-Tuina interventions in adults with cNLBP. PubMed, EMBASE, Web of Science, Cochrane Library, CNKI, CBM, WanFang, and VIP were searched from inception to April 2025. The Cochrane Risk of Bias tool and the GRADE approach were applied to assess risk of bias and certainty of evidence. Twenty-one trials (1612 participants) were included. Compared with control interventions, Tuina showed greater pain reduction (SMD = -1.06, 95% CI: [-1.37, -0.76], p < 0.00001, GRADE: low), better functional improvement (SMD = -1.17, 95% CI: [-1.62, -0.72], p < 0.00001, GRADE: low), and superior clinical effectiveness (OR = 3.84, 95% CI: [2.42, 6.11], p < 0.00001, GRADE: low). No significant differences were found in muscle fitness (SMD = 1.42, 95% CI: [-0.00, 2.83], p = 0.05, GRADE: very low) or incidence of serious adverse events. Tuina effectively treats cNLBP, offering substantial pain relief and functional improvements, though it has no significant impact on muscle fitness. Future work should consider standardized protocols and more rigorously designed trials to support clinical recommendations. This study has been registered with the PROSPERO platform (registration no. CRD420251051014).

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Huang B, Xie H, Duan M, et al. Tuina for chronic non-specific low back pain: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2026. PMID: 42002161. doi:10.1016/j.ctim.2026.103381

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。